Likewise, in 2017, Lapa et al., conducted a clinical study in 35 patients with multiple myeloma (MM) for PET imaging of CXCR4 (Figure 14), and the results were compared with those of [18F]FDG [137]. This evidence concerns the gene CXCR4 and plasma cell myeloma.